These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37072061)

  • 1. Recent advancements in snake antivenom production.
    Rathore AS; Kumar R; Tiwari OS
    Int J Biol Macromol; 2023 Jun; 240():124478. PubMed ID: 37072061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
    Alomran N; Alsolaiss J; Albulescu LO; Crittenden E; Harrison RA; Ainsworth S; Casewell NR
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009659. PubMed ID: 34407084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
    Alomran N; Blundell P; Alsolaiss J; Crittenden E; Ainsworth S; Dawson CA; Edge RJ; Hall SR; Harrison RA; Wilkinson MC; Menzies SK; Casewell NR
    Toxins (Basel); 2022 Jun; 14(7):. PubMed ID: 35878181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
    Offor BC; Muller B; Piater LA
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
    Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
    J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India.
    Attarde S; Iyer A; Khochare S; Shaligram U; Vikharankar M; Sunagar K
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
    Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
    Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative Immunization Strategies for Antivenom Development.
    Bermúdez-Méndez E; Fuglsang-Madsen A; Føns S; Lomonte B; Gutiérrez JM; Laustsen AH
    Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30400220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review.
    Soopairin S; Patikorn C; Taychakhoonavudh S
    PLoS One; 2023; 18(7):e0288723. PubMed ID: 37467278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics meets biology: application to the design and preclinical assessment of antivenoms.
    Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
    Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snake antivenom: Challenges and alternate approaches.
    Alangode A; Rajan K; Nair BG
    Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering and design considerations for next-generation snakebite antivenoms.
    Knudsen C; Ledsgaard L; Dehli RI; Ahmadi S; Sørensen CV; Laustsen AH
    Toxicon; 2019 Sep; 167():67-75. PubMed ID: 31173790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the Cross-Neutralisation Potential of Existing Antivenoms for Mitigating the Outcomes of Snakebite in Sub-Saharan Africa.
    Khochare S; Jaglan A; Rashmi U; Dam P; Sunagar K
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANAVIP® interaction with western pygmy rattlesnake venom: In vitro assesment of reactivity using SE-HPLC.
    Tanner DA; Shults CA; Sanny C
    Toxicon; 2020 Dec; 188():159-163. PubMed ID: 33096151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies as Snakebite Antivenoms: Past and Future.
    Dias da Silva W; De Andrade SA; Megale ÂAA; De Souza DA; Sant'Anna OA; Magnoli FC; Guidolin FR; Godoi KS; Saladini LY; Spencer PJ; Portaro FCV
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against Naja kaouthia, Naja siamensis and Ophiophagus hannah through proteomics and animal model approaches.
    Liu CC; You CH; Wang PJ; Yu JS; Huang GJ; Liu CH; Hsieh WC; Lin CC
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006138. PubMed ID: 29244815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.